The use of medicinal plants in modern medicine suffers from the fact that although hundreds of plants are used in the world to prevent or to cure diseases, scientific evidence in terms of modern medicine is lacking in most cases. However, today it is necessary to provide scientific proof as to whether it is justified to use a plant or its active principles.
2) As far as modern drugs are concerned, they must be further characterized after their pharmacological screening, i.e., for pharmacokinetic and pharmacodynamic properties, including toxicity.
3) A recent upsurge in identifying non-dietary natural products associated with a high degree of safety margin as cancer chemopreventive agents has been hailed by many investigators to be practically beneficial, especially when the carcinogenic effect is mild to moderate.
Cancer chemoprevention is an exciting pharmaceutical cancer research involving the use of either natural or synthetic components to delay, inhibit or reverse the development of cancer in normal or preneoplastic conditions. There have been considerable efforts to search for naturally occurring substances that can inhibit, reverse or retard the multistage carcinogenesis. A wide array of substances present in the medicinal herbs or dietary plants has been screened for their ability to prevent carcinogenicity. A large number of medicinal or dietary plants have been shown to exhibit substantial inhibitory effects on experimentally induced carcinogenesis and in many cases their chemopreventive activities are associated with antioxidative and/or anti-inflammatory properties. In our laboratory plant extracts such as Ocimum, 4) Spirulina, 5) Brassica, 6) Mentha 7) and ginseng 8, 9) have shown to have anticancer potential against 7,12 dimethylbenz(a)anthracene (DMBA) and croton oil induced skin papillomagenesis in Swiss albino mice.
Ginseng is an oriental herbal remedy, which has been in use for the last 5000 years. Extensive research has shown that ginseng contains medicinally useful substances such as ginsenosides, minerals-iron, copper, zinc, Mn, Mg, germanium, phosphorus, sulphur etc. enzymes, carbohydrates, aminoacids, proteins, peptides, flavonoids, essential oils, fatty acids, phytosterols, crude fibres, adenosine, maltol and phenolic compounds. Ginseng has been shown to possess pharmacological properties including "antifatigue" and "antistress" actions, normalizing effects on carbohydrate metabolism, and stimulating effect on the central nervous system. It has also adaptogenic property. In the present investigation an attempt has been made to evaluate the anticancer potential of Panax ginseng extract, EFLA400, against lung adenoma induced by benzo(a)pyrene using Yun's medium term anticarcinogenicity test model in Swiss albino mice.
MATERIALS AND METHODS

Animals
Newborn Swiss albino mice (less than 24 h old) were used for experiments. These animals with their mothers were maintained in the animal house at temperatures of 24Ϯ3°C and a light (14 h light : 10 h dark). They were housed in polypropylene cages and fed standard mice feed (to mothers) from Hindustan Lever Ltd., India. Tap water was provided to the animals.
Ginseng Extract The ginseng extract EFLA400 (Phoenix ginseng) (Batch 303298) prepared according to the published procedure, (Reference: Korean Patent 0425022, PCT/KR2003/000003) was supplied from Lotte Group R&D Center (Seoul, Korea).
In brief ginseng extract EFLA400 (Phoenix ginseng) is produced by decoction of Panax ginseng (approx. 90%) and Hawthorn berry (approx. 10%) under the patented specific manufacturing process. The nature of Hawthorn berry promotes conversion of ginsenosides present in natural Panax
In the present investigation the chemopreventive action of Panax ginseng extract, EFLA400, in Swiss albino mice has been evaluated. We used a 9-week medium term anticarcinogenicity test model of lung adenomas [Yun et al. 1) ]. Lung adenomas were induced by single subcutaneous injection in the subscapular region with 0.02 ml of benzo(a)pyrene (BP) (0.5 mg suspension in 1% aqueous gelatin) in newborn mice (less than 24 h old). Also chromosomal aberrations and micronuclei induction were evaluated in bone marrow cells. These genotoxicity endpoints were compared with adenoma incidence at the same dose levels of BP and EFLA400. The oral administration of EFLA400 (10 mg/kg body weight) showed significant reduction in number of adenomas and weight of the lungs induced by BP. A significant reduction (pϽ0.001) in lung adenoma incidence in EFLA400-treated mice was observed as compared to the 68.3؎2.96% lung adenoma incidence in BP-alone group. The inhibition rate was 72.05؎1.36% in EFLA400-treated group with respect to the reference group (BP-alone group). However, tumor multiplicity was observed as 0.91؎0.08 and 0.25؎0.01 in BP alone and BP؉EFLA400-treated groups respectively. In EFLA400-treated group significantly reduced frequencies of chromosomal aberrations and micronuclei induced by BP were observed. The results of the present investigation suggest the chemopreventive action and antimutagenic effect of EFLA400 in Swiss albino mice induced by BP in newborn mice.
ginseng to therapeutically more active ginsenosides. The content of ginsenoside Rg3, a pharmacologically active ingredient of the EFLA400 was Ͼ3.0% (w/w), as determined by HPLC, modified method of Kwon et al.
10) The quality control is being carried out with the contents of Rg3 by HPLC using C18 reverse phase column and gradient solvent system. The ginsenosides are very labile under acidic condition. Therefore it is necessary to standardize ginseng extract in order to expect constant quality and efficacies.
Experimental Design. Medium Term Anticarcinogenicity Test Model (Yun's Model) Newborn Swiss albino mice less than 24 h old were subcutaneously injected once in the scapular region with 0.02 ml of benzo(a)pyrene (BP, 0.5 mg suspension in 1% aqueous gelatin). After weaning, test material was administered for 6 weeks through oral gavage. All animals were sacrificed at the 9th week after birth. 1) Group-I (No BP, no EFLA400): After weaning, vehicle Tween 80 (volume equal to EFLA400) was administered for 6 weeks through oral gavage.
Group-II (EFLA400 Alone): After weaning, EFLA400 (10 mg/kg body weight) was administered for 6 weeks through oral gavage.
Group-III (BP Alone): This group of animals was subcutaneously injected once in the scapular region with 0.02 ml of BP.
Group-IV (BPϩEFLA400): The animals of this group were subcutaneously injected once in the scapular region with 0.02 ml of BP. After weaning, EFLA400 (10 mg/kg body weight) was administered for 6 weeks through oral gavage.
Lungs were excised and fixed in Tellyesniczky's solution (100 ml of 70% ethanol, 3 ml formalin, 5 ml glacial acetic acid), and the number of the adenoma were counted by the naked eyes. To obtain an index of tumor incidence, the percentage of tumor bearing mice per total number of mice in each group was calculated. Tumor multiplicity was defined as the average number of tumors per mouse obtained, by dividing the total number of tumors by the total number of mice per group including nontumor-bearing animals. Statistical comparison was made using the Student's 't' test.
Cytogenetic Study. Chromosomal Aberration Analysis Cytogenetic damage in the bone marrow cells was studied by chromosomal aberration analysis at the end of the experiments. All the animals were injected i.p. with 0.025% colchicine and sacrificed 2 h later by cervical dislocation.
Both femurs were dissected out. Metaphase plates were prepared by the air drying method. 11) Bone marrow from the femur was aspirated, washed in saline, treated hypotonically (0.6% sodium citrate), fixed in 3 methanol: 1 acetic acid, dried and stained with 4% Giemsa (Sigma, U.S.A.). Different types of aberration like chromatid breaks, chromosome breaks, fragments, rings, exchanges and dicentrics were scored. When breaks involved both the chromatids, it was termed "chromosome type" aberration, while "chromatid type" aberration involved only one chromatid. If the deleted portion had no apparent relation to a specific chromosome, it was called a fragment. 12) Chromosomal aberrations were scored under a light microscope. A total of 400 metaphase plates were scored per animal and each aberration type was calculated in percentage.
Micronuclei Assay The method of Schmid 13) was employed for the micronucleus assay. The femurs were dissected out and the bone marrow was flushed out, vortexed and centrifuged. The pellet was resuspended in a few drops of fetal calf serum. Smears were made on pre-cleaned, dry slides, air dried and fixed in absolute methanol. The slides were stained with May-Grunwald's and Giemsa stain. At least 2000 erythrocytes were observed and the number of polychromatic erythrocytes and normochromatic erythrocytes were counted. The micronuclei in them were recorded and micronuclei per 1000 cells were calculated.
RESULTS
In Group III, in which a newborn Swiss albino mice less than 24 h old were subcutaneously injected once in the scapular region with 0.02 ml of benzo(a)pyrene, a significant reduction in body weight and weight of lungs was observed at the termination of experiment (9 weeks). The lung adenoma incidence was 68.3Ϯ2.96% and tumor multiplicity was 0.91Ϯ0.08 in this group (Tables 1, 2) .
In treatment group (Group IV, BPϩEFLA400), animals showed significantly less number of lung adenomas also significant increase (pϽ0.05) was also observed in the weight of lungs. In this group the percentage of lung adenoma incidence and inhibition rate was also less (pϽ0.001) as compared to the BP-alone group. The average weight of mice in Group III (BP-alone) was 19.3Ϯ0.4 g whereas it was significantly increased in EFLA400-treated group (24.0Ϯ0.47). A significant decrease in the number of adenomas was ob- served in EFLA400-treated group (Table 1) . The lung adenoma incidence was 68.3Ϯ2.96% in control group whereas it was 19.1Ϯ1.64 in EFLA400-treated group ( Table 2 ). The inhibition rate was 72.05Ϯ1.36% in EFLA400-treated group with respect to reference (Group III). The tumor multiplicity was 0.91Ϯ0.08 in mice treated with 0.5 mg of BP. However, when treated with EFLA400 it was 0.25Ϯ0.01 (pϽ0.001).
Chromosomal aberrations analysis showed single subcutaneously injected once in the scapular region with 0.02 ml BP in newborn mice was able to induce significantly increased chromosomal anomalies in bone marrow cells (Group III). In this group, significant increase in chromosomal aberrations in the form of chromatid breaks, chromosome breaks, centric rings, dicentrics, exchanges and acentric fragments were observed (Table 3) . Also significant increase in percentage of pulverized cells, polyploids, total aberrations and aberrations/damaged cells were recorded in this group of animals. The frequencies of induced micronuclei in control group of animals were observed as 20.82Ϯ1.81%. Whereas, in the treatment group (Group-IV), significant decrease in chromosomal aberrations and micronuclei frequencies were observed as compared to control group (Tables 4, 5) .
DISCUSSION
The present study demonstrated that the oral administra- tion of EFLA400 has chemopreventive activity against BPinduced lung adenomas in Swiss albino mice. The extract treatment showed significant reductions in lung adenoma incidence, tumor multiplicity and significant increases in body weight, inhibition rate, and lung weight induced by BP in newborn mice. Cancer chemoprevention is defined as the use of chemicals or dietary components to block, inhibit or reverse the development of cancer in normal or preneoplastic tissue. A large number of potential chemopreventive agents have been found to function by a variety of mechanisms directed at all major stages of carcinogenesis. Previous studies have demonstrated that one avenue for chemoprotection against toxic mutagenic chemicals and anticarcinogenicity is induction of the drugmetabolizing enzymes that interfere with bioactivation and accelerate the detoxification process. [14] [15] [16] [17] Many carcinogens and mutagens are not active per se and must be activated into reactive electrophiles before exerting their biologic effects. 18, 19) Accumulating evidence supports the hypothesis that several naturally occurring inducers present in common edible plant parts exhibit an inhibitory effect on carcinogenesis. 14, [20] [21] [22] [23] The inhibitory action of the these compounds is related to factors such as the prevention of formation of the carcinogen, induction of coordinated enzyme response and scavenging of active metabolites of the carcinogen. 24, 25) These agents modify or suppress the carcinogen action on critical target sites in the cell.
In the present study, EFLA400-treatment showed significant decrease in chromosomal aberrations and micronuclei frequencies. Several findings concerning the action of tumor promoters and the process of tumor promotion in the mouse skin system have been discussed and interpreted such as the frequency, reversibility and transient nature of conversion, dependence of tumor promotion on DNA synthesis, induction of DNA breaks by tumor promoters, and the protective effect of scavengers of free radicals. It has been suggested that tumor formation in mouse skin and other systems to proceed in discrete, genetically determined steps, initiation is considered to be due to the induction of point mutations in a dominant acting oncogene that becomes thereupon activated, whereas the decisive event in the conversion stage of tumor promotion is the induction of numerical and/or structural chromosomal changes with the consequence of loss or inactivation of gene(s) involved in the tumor phenotype. 26) Multani et al. 27) have reported that loss of telomeric repeats arrests cells in the G 2ϩ M phase. Chromosomes in such cells divide but the cytoplasm does not, resulting in endoreduplication and tetraploid cell formation. These cells with their chromosomes undergoing continued loss of telomeres have shown severe DNA fragmentation and ultimately cell death. Telomere erosion under certain unknown conditions also induces genetic instability, which, in turn, may activate the reverse transcriptase enzyme telomerase, oncogenes, and loss of tumor suppressor genes. 28, 29) Since telomeres are the guardians of the chromosomes and, therefore, of the genome, their erosion resulting may cause telomere dysfunction. 30) Certain fractions or purified individual ingredients of ginseng have been shown to exert cytotoxic or cytostatic activities against tumor cells in culture. [31] [32] [33] [34] The growth inhibitory or anti-proliferative effects of certain ginsenosides appear to be associated with their capability to induce apoptosis. 34, 35) The growth of human ovarian cancer cells inoculated into nude mice was significantly inhibited by ginsenoside Rh 2 after oral administration. 36) In addition the antimetastatic potential of ginseng saponins has been demonstrated in several animal tumor models. [37] [38] [39] [40] Ginsenoside Rg3 was found to be a potent inhibitor of tumor cell invasion in vitro. 41) The methanolic extract of red ginseng enhanced the uptake of mitomycin C by the tumor cells and potentiated its cytotoxic effect. 31) Likewise, panaxytriol potentiated the mitomycin C-induced cytotoxicity in cultured cancer cell. 32) The root extracts of Panax ginseng also exhibit protective effects against mutation of NIH3T3 cells induced by some chemical carcinogens. 42) Ginsenoside Rh 2 present in red ginseng has been reported to suppress the formation of sister chromatid exchanges in human blood lymphocytes. 43) Moreover, recent epidemiological studies have demonstrated that ginseng intake is associated with a reduced risk for environmentally related cancers such as esophageal, gastric, colorectal and pulmonary tumors. 44, 45) However, only limited data are available in the literature with regard to chemopreventive effects of ginseng on experimental carcinogenesis. [46] [47] [48] Yun et al. 46) reported that prolonged administration of extracts of Korean red ginseng resulted in substantial supression of pulmonary tumorigenesis induced by such chemical carcinogens as DMBA, urethane, aflatoxin B1, or BP.
Recently, we have reported that the oral administration of EFLA400 at pre, peri and post-initiational phases showed significant reduction in tumor incidence, tumor burden, tumor weight, tumor size and cumulative number of papillomas and significant increase in average latent period induced by DMBA in Swiss albino mice in skin tumor model system.
9) It was also noted that EFLA400-treated group significantly reduced frequencies of chromosomal aberrations and micronuclei induced by BP were observed. The chemopreventive action and antimutagenic effect of the EFLA400 containing high titer of ginsenoside Rg3 (Ͼ3.0% w/w) in Swiss albino mice against benzo(a)pyrene may be due to the immunomodulatory and pharmacological properties of Panax ginseng. Kumar 49) has shown that ginseng has immunomodulatory effects and its action is primarily mediated by macrophages. The immunological response is activation of NK cells through the secretion of Interleukin-2. This helps in killing the tumor target cells more efficiently. There are few reports regarding possible pharmacological mechanism of ginsenoside on cancer preventive effects. It has been reported that methanolic extract of heat processed Panax ginseng attenuates the lipid peroxides in rat brain homogenates and is capable of scavenging superoxide generated by xanthine oxidase or by 12-O-tetradecanoylphorbol-13-acetate (TPA) in differentiated human promyelocytic leukemia (HL-62) cells. 50) Further EFLA400 contains 3 percent Rg3. It has been reported that Rg3 pretreatment abrogated the expression of cyclooxygenase-2 in TPA stimulated mouse skin. It also inhibited the TPA induced activation of eukaryotic transcription factor NF-kB in both mouse skin and of promyelocytic leukemia (HL-62) cells. 51) 
